With 2019 reporting to CMS Open Payments (Sunshine Act) now complete, it’s a great time to reflect on how you can improve your current reporting processes for next year. The March 31, 2020 reports presented a number of unique reporting challenges, with CMS rolling out new validation requirements for zip codes, drug names, and National Drug Codes (NDCs).
Additionally, CMS tightened its state licensing data validation. If the state license number submitted had expired prior to the start of the Open Payments program on August 1, 2013, the associated record was rejected. Many internal transparency teams and other Aggregate Spend vendors faced difficulties adapting to these new requirements and filling the gaps in their data needed to comply.
How Did Medpro Support Our Customers with These Challenges?
We updated Porzio AggregateSpendID, our industry-leading end-to-end Aggregate Spend tracking and reporting solution, to identify invalid zip codes so that updates could be made prior to their submission to CMS. We additionally used CMS’ Drug Name and National Drug Code Reference Data as the source for reported drug names to assure alignment with the validation source.
Our Aggregate Spend solution is powered by MedProID, the Life Sciences industry’s most comprehensive healthcare practitioner (HCP) and healthcare organization (HCO) record database, which includes 20+ years of historical license data. By leveraging this data, our team was able to quickly identify and adapt to new Federal requirements on state licensure expiration and validation across millions of practitioners.
If your internal team or your current transparency vendor faced difficulties this year with the challenges above, MedPro Systems is here to help.
Contact us today to discuss how we can help you with next year’s Open Payments reporting, as well as the state and local reporting deadline approaching on July 1, 2020.